🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective of this study is to compare the tolerability and adheren...
Status
Completed
Location
Hospital clínico y provincial de Barcelona
Start Date
2015-06-06
Trial ID
NCT02198443
The primary objective of this study is to evaluate the efficacy of switchin...
Status
Completed
Location
Multiple Locations
Start Date
2016-02-19
Trial ID
NCT02652624
This study will evaluate the efficacy of Stribild® (elvitegravir/cobicistat...
Status
Completed
Location
Kaiser Permanente Los Angeles
Start Date
2012-01
Trial ID
NCT01533259
Treatments Being Tested
To evaluate the safety and efficacy of Stribild®, a single tablet regimen (...
Status
Completed
Location
Spectrum Medical Group
Start Date
2010-04
Trial ID
NCT01106586
Treatments Being Tested
Atripla and Stribild are two FDA-Approved one pill a day combination antire...
Status
Unknown
Location
Hawaii Center for AIDS
Start Date
2014-09
Trial ID
NCT02283060
In this study we will use a multi-modal imaging approach of MRS and fMRI to...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2014-01
Trial ID
NCT01929759
Treatments Being Tested
This study will evaluate the noninferiority of Stribild® (elvitegravir/cobi...
Status
Completed
Location
Spectrum Medical Group
Start Date
2011-12
Trial ID
NCT01495702
Changes in insulin resistance in healthy volunteers with normal body weight...
Status
Completed
Location
University Hospital Klinikum rechts der Isar (TUM)
Start Date
2014-07
Trial ID
NCT02203461
This study is to characterize the effect of cobicistat-based regimens on pa...
Status
Completed
Location
Spectrum Medical Group
Start Date
2011-05
Trial ID
NCT01363011
Elvitegravir is an HIV-1 integrase inhibitor which is marketed in a fixed d...
Status
Completed
Location
CRCN, Radboud University Medical Center
Start Date
2015-02
Trial ID
NCT02325934
Treatments Being Tested